Company Valuation: OPC Pharmaceutical

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 1,581,348 1,520,220 1,761,400 1,537,221 1,601,272 1,537,221
Change - -3.87% 15.86% -12.73% 4.17% -4%
Enterprise Value (EV) 1 1,568,096 1,373,409 1,446,194 1,215,860 1,353,985 1,218,052
Change - -12.42% 5.3% -15.93% 11.36% -10.04%
P/E 15x 12.1x 13.8x 14.7x 17.6x 15.6x
PBR 2.45x 2.23x 2.18x 1.87x 1.97x 1.69x
PEG - 0.6x 8.41x -0.8x -1.3x 1.89x
Capitalization / Revenue 1.64x 1.35x 1.5x 1.53x 1.65x 1.37x
EV / Revenue 1.62x 1.22x 1.23x 1.21x 1.4x 1.08x
EV / EBITDA 9.92x 7.26x 7.18x 7.19x 8.64x 7.92x
EV / EBIT 11.5x 8.24x 8.1x 8.32x 10.1x 9.21x
EV / FCF 16x 6.71x 9.7x 12.8x 106x 21.3x
FCF Yield 6.26% 14.9% 10.3% 7.78% 0.94% 4.7%
Dividend per Share 2 1,064 - 1,282 1,282 - 683.8
Rate of return 5.04% - 5.45% 6.25% - 3.33%
EPS 2 1,408 1,682 1,709 1,397 1,214 1,314
Distribution rate 75.6% - 75% 91.8% - 52%
Net sales 1 965,591 1,123,728 1,171,614 1,004,887 968,576 1,122,987
EBITDA 1 158,152 189,215 201,454 169,015 156,652 153,844
EBIT 1 136,411 166,713 178,636 146,120 134,434 132,289
Net income 1 105,791 126,377 142,128 122,234 107,060 115,881
Net Debt 1 -13,252 -146,811 -315,205 -321,361 -247,287 -319,169
Reference price 2 21,101.54 20,285.85 23,504.27 20,512.82 21,367.52 20,512.82
Nbr of stocks (in thousands) 74,940 74,940 74,940 74,940 74,940 74,940
Announcement Date 3/15/21 3/7/22 3/15/23 3/22/24 3/27/25 3/23/26
1VND in Million2VND
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 62.13M
35.03x12.19x25.61x0.59% 1,024B
27.48x6.29x17.54x2.1% 618B
32.57x7.42x15.35x2.76% 443B
19.7x4.68x11.59x2.83% 349B
21.76x4.48x12.7x1.96% 264B
13.48x5.05x10.4x3.71% 209B
25.29x6.61x11.66x2.62% 208B
-46.92x5.63x31.08x2.53% 162B
12.69x3.11x7.86x6.88% 143B
Average 15.68x 6.16x 15.98x 2.89% 341.9B
Weighted average by Cap. 24.04x 7.68x 18.14x 2.14%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. OPC Stock
  4. Valuation OPC Pharmaceutical